NHS
UK government launches ‘Sign up to Safety’ initiative
March 26, 2014Sales and Marketing Francis, Hunt, Mid Staffs, NHS, safety, sign up
A new ambition to reduce avoidable harm in the NHS by half over the next three years, cut costs and …
Pfizer’s Xalkori impresses in new setting
March 26, 2014Research and Development, Sales and Marketing NHS, NICE, NSCLC, Pfizer, Xalkori, lung cancer
Pfizer’s lung cancer treatment Xalkori has proven better at treating patients in a first-line setting when compared to chemotherapy. This …
NICE says ‘no’ to Xofigo
March 24, 2014Sales and Marketing Bayer, CDF, NHS, NICE, abiraterone, prostate, xofigo
NICE has dealt Bayer a severe blow by not approving prostate cancer drug Xofigo for use on the NHS in …
Data transparency debate: Europe decides its future
March 24, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EFPIA, EMA, EU, Goldacre, NHS, alltrials, european, transparency
Transparency became a major issue in 2013 as various new pressure groups sprung up with the shared aim of forcing …
NICE approves Velcade
March 21, 2014Sales and Marketing Janssen, NHS, NICE, Velcade, myeloma
NICE has recommended Janssen’s proteasome inhibitor Velcade as an induction treatment for some patients with newly-diagnosed multiple myeloma. The draft …
NHS unions threaten action
March 14, 2014Sales and Marketing Hunt, NHS, UK, nhsprb, nurses
Unions representing NHS staff in England have reacted strongly to a new round of below-inflation pay rises and have threatened …
BIA ‘disappointed’ by early access funding
March 14, 2014Research and Development, Sales and Marketing BIA, NHS, bates, dams, early access
The BioIndustry Association (BIA) is ‘disappointed’ that the government is not funding the much-anticipated Early Access to Medicines Scheme (EAMS). …
Sizeable increase to NHS prescription fees
March 12, 2014Sales and Marketing Hunt, Lamb, NHS, UK, howe, prescriptions
The UK government has confirmed that NHS prescription charges will go up by 40p to £8.25 over the next two …
Roche makes Manchester connection
March 12, 2014Research and Development, Sales and Marketing Manchester, NHS, Roche, ahsc, mahsc
Roche has signed a deal with a research group in the north-west of England to develop ideas which it hopes …
Proteus to trial smart pills in UK
March 11, 2014Medical Communications, Sales and Marketing NHS, helius, nhsa, proteus, smart pills, ukti
A US biotech specialising in smart pills is to set up its first manufacturing site in the UK creating 200 …
ABPI worried about Prolia use
March 10, 2014Sales and Marketing ABPI, Amgen, NHS, Xgeva
The ABPI has once again voiced concern that NHS patients in some areas of England are not getting access to …
First payments made under PPRS scheme
March 7, 2014Sales and Marketing ABPI, NHS, abp. pars, government
The first payments in pharma’s new pricing deal with the Department of Health are to be made this month as …
Smartphone tech to help autism sufferers commended
March 6, 2014Medical Communications, Sales and Marketing NHS, asperger's, aspergers, autism, brain in hand, cloud, digital
Smartphone technology which helps people with autism to live more easily with their condition has been commended as part of …
NICE U-turn on Pfizer drug Inlyta
March 5, 2014Research and Development, Sales and Marketing Kidney cancer, NHS, NICE, Pfizer, axitinib, inlyta
NICE has recommended that Pfizer’s kidney cancer drug Inlyta should be used for some patients in England, following a similar …
Latest content
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?
